Seeking Alpha

Myriad Genetics (MYGN): Q3 EPS of $0.33 misses by $0.06. Revenue of $91M (+5%) vs. $98M. Shares...

Myriad Genetics (MYGN): Q3 EPS of $0.33 misses by $0.06. Revenue of $91M (+5%) vs. $98M. Shares -18.5% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs